Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists
Alessandro Bonifazi, Hideaki Yano, Adrian M. Guerrero, et al.
ACS Pharmacology & Translational Science (2019) Vol. 2, Iss. 1, pp. 52-65
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 190
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
Per Plenge, Dongxue Yang, Kristine Salomon, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 66
2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 5, pp. 1779-1797
Open Access | Times Cited: 62
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
Elise Wouters, Jolien Walraed, Michael J. Robertson, et al.
ACS Pharmacology & Translational Science (2019) Vol. 3, Iss. 2, pp. 285-295
Open Access | Times Cited: 56
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity
Marta Sánchez‐Soto, Ravi Kumar Verma, Blair K. A. Willette, et al.
Science Signaling (2020) Vol. 13, Iss. 617
Open Access | Times Cited: 41
Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism
J. Robert Lane, Ara M. Abramyan, Pramisha Adhikari, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 35
Ligand-directed bias of G protein signaling at the dopamine D2 receptor
Ee Von Moo, Kasper Harpsøe, Alexander S. Hauser, et al.
Cell chemical biology (2021) Vol. 29, Iss. 2, pp. 226-238.e4
Open Access | Times Cited: 28
Generation of Gαi knock-out HEK293 cells illuminates Gαi-coupling diversity of GPCRs
Yuki Ono, Kouki Kawakami, Gaku Nakamura, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 11
The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective Agonists
Francisco O. Battiti, Sophie L. Cemaj, Adrian M. Guerrero, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 13, pp. 6287-6314
Open Access | Times Cited: 32
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization
Kyeong‐Man Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6742-6742
Open Access | Times Cited: 10
Linkers in Bitopic Agonists Shape Bias Profile among Transducers for the Dopamine D2 and D3 Receptors
Ana Semeano, Rian Garland, Alessandro Bonifazi, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2333-2349
Open Access | Times Cited: 3
Progress on the development of Class A GPCR‐biased ligands
Paula Morales, Magdalena M. Scharf, Marcel Bermúdez, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
Positive Allosteric Modulation of the 5-HT1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans
Hideaki Yano, Pramisha Adhikari, Sett Naing, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 10, pp. 1400-1405
Open Access | Times Cited: 25
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome
Mark J. Henderson, Kathleen A. Trychta, Shyh‐Ming Yang, et al.
Cell Reports (2021) Vol. 35, Iss. 4, pp. 109040-109040
Open Access | Times Cited: 22
New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling
Anika Mann, Alastair C. Keen, Hanka Mark, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21
TRUPATH: An Open-Source Biosensor Platform for Interrogating the GPCR Transducerome
Jeffrey F. DiBerto, Reid H. J. Olsen, Bryan L. Roth
Methods in molecular biology (2022), pp. 185-195
Closed Access | Times Cited: 16
Chemical biology of noncanonical G protein–coupled receptor signaling: Toward advanced therapeutics
Maria M. Shchepinova, Aylin C. Hanyaloglu, Gary Frost, et al.
Current Opinion in Chemical Biology (2020) Vol. 56, pp. 98-110
Closed Access | Times Cited: 21
Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management
Alessandro Bonifazi, Francisco O. Battiti, Julie Sanchez, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7778-7808
Open Access | Times Cited: 20
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
Pramisha Adhikari, Bing Xie, Ana Semeano, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 570-570
Open Access | Times Cited: 16
Comparison of the function of two novel human dopamine D2 receptor variants identifies a likely mechanism for their pathogenicity
Dayana Rodriguez‐Contreras, Javier García‐Nafría, Amy Chan, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116228-116228
Closed Access | Times Cited: 2
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach
Marie Emilie Hovah, Ulrike Holzgrabe
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2545-2599
Open Access | Times Cited: 2
D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine
Yudao Shen, John D. McCorvy, Michael L. Martini, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 9, pp. 4755-4771
Open Access | Times Cited: 18
Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D2/D3 Receptor Bitopic Ligands
Anver Basha Shaik, Comfort A. Boateng, Francisco O. Battiti, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 20, pp. 15313-15333
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top